Abstract
Hyperemesis gravidarum (HG) is characterized by unrelenting nausea and vomiting in pregnancy and may be accompanied by weight loss, electrolyte abnormalities, and dehydration. Prompt recognition and early efforts to control symptoms are essential to limiting progression of disease. Fluid and electrolyte repletion, as well as pharmacologic control of symptoms, is the mainstay of acute HG management. Pharmacologic therapy includes dopamine antagonists, selective serotonin inhibitors, and H1 antagonists. For patients with prolonged symptoms, treatment should include supplemental folate and thiamine. Admission is reserved for patients with significant electrolyte abnormalities or severe symptoms refractory to pharmacologic intervention.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sheehan P. Hyperemesis gravidarum – assessment and management. Aust Fam Physician. 2007;36(9):698–701.
World Health Organization. International classification of diseases: 10. Version: 2010. 2012. http://tinyurl.com/ctcuekp. Accessed 29 June 2016.
Kuscu NK, Koyuncu F. Hyperemesis Gravidarum: current concepts and management. Postgrad Med J. 2002;78(916):76–9.
Ismail SK, Kenny L. Review on hyperemesis gravidarum. Clin Gastroenterol. 2007;21(5):755–69.
American College of obstetricians and gynecologists practice bulletin summary no. 153. Obstet Gynecol. 2015;126(3):687–8.
Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009;360(24):2528–35.
Pasternak B, Svanström H, Hvild A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368:814–23. Erratum in N Engl J Med 2013;368:2146.
Danielsson B, Wikner BN, Källén B. Use of ondansetron during pregnancy and congenital malformations in the infant. Reprod Toxicol. 2014;50:134–7.
Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014;123:1272–9.
Magee LA, Mazzotta P, Koren G. Evidence- based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S256–61. 37.
Fischer-Rasmussen W, Kiaer SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 1991;38(1):19–24.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
DeGeorge, L., Wiesner, L. (2019). What Are the Best Management Strategies for Hyperemesis Gravidarum?. In: Graham, A., Carlberg, D.J. (eds) Gastrointestinal Emergencies. Springer, Cham. https://doi.org/10.1007/978-3-319-98343-1_109
Download citation
DOI: https://doi.org/10.1007/978-3-319-98343-1_109
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98342-4
Online ISBN: 978-3-319-98343-1
eBook Packages: MedicineMedicine (R0)